Literature DB >> 6699141

Nosocomial colonization and infection by Achromobacter xylosoxidans.

M E Reverdy, J Freney, J Fleurette, M Coulet, M Surgot, D Marmet, C Ploton.   

Abstract

Achromobacter xylosoxidans, a bacterial species named in 1971, is often isolated from aqueous environments, but little has been reported about its pathogenicity in humans, its epidemiological pattern, and its susceptibility to antibiotics and antiseptics. We were faced with an epidemic caused by this microorganism for 18 months in an intensive care unit. Two patients had fatal infections and 37 others were colonized. The source was the deionized water of the hemodialysis system. The 46 isolates were identified by comparison with the reference strain A. xylosoxidans ATCC 27061. The characteristic cellular fatty acids of this species were demonstrated by gas-liquid chromatography. The minimal inhibitory concentrations of 27 antibiotics were determined. The isolates were susceptible to only two: moxalactam at 4 micrograms/ml and ceftazidime at 8 micrograms/ml. The minimal bactericidal concentrations of one disinfectant and three antiseptics were: sodium hypochloride, 109 micrograms/ml; chlorhexidine digluconate in ethanol solution, 15 to 125 micrograms/ml; polyvinylpyrrolidone iodine, 750 micrograms/ml; and iodine ethanol, 312 to 625 micrograms/ml.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6699141      PMCID: PMC271003          DOI: 10.1128/jcm.19.2.140-143.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Achromobacter septicemia-fatalities in prematures. I. Clinical and epidemiological study.

Authors:  J F FOLEY; C R GRAVELLE; W E ENGLEHARD; T D CHIN
Journal:  Am J Dis Child       Date:  1961-03

2.  Achromobacter meningitis in the newborn.

Authors:  S L Lee; K L Tan
Journal:  Singapore Med J       Date:  1972-10       Impact factor: 1.858

3.  Achromobacter xylosoxidans n. sp. from human ear discharge.

Authors:  E Yabuuchi; A Oyama
Journal:  Jpn J Microbiol       Date:  1971-09

4.  Achromobacter meningitis in the newborn.

Authors:  S S Sindhu
Journal:  J Singapore Paediatr Soc       Date:  1971-04

5.  [A case of suppurative skin disease which is thought to be due to Achromobacter xylosoxidans (author's transl)].

Authors:  N Toki; H Kitaura
Journal:  Nihon Hifuka Gakkai Zasshi       Date:  1980-08

6.  Achromobacter xylosoxidans isolates in Hawaii.

Authors:  F D Pien; H Y Higa
Journal:  J Clin Microbiol       Date:  1978-02       Impact factor: 5.948

7.  Identification of Achromobacter species by cellular fatty acids and by production of keto acids.

Authors:  S B Dees; C W Moss
Journal:  J Clin Microbiol       Date:  1978-07       Impact factor: 5.948

8.  Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.

Authors:  C H O'Callaghan; A Morris; S M Kirby; A H Shingler
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

9.  Pancreatic abscess associated with Achromobacter group Vd biovar 1.

Authors:  P C Appelbaum; D B Campbell
Journal:  J Clin Microbiol       Date:  1980-08       Impact factor: 5.948

10.  Cerebral ventriculitis associated with Achromobacter xylosoxidans.

Authors:  S Shigeta; Y Yasunaga; K Honzumi; H Okamura; R Kumata; S Endo
Journal:  J Clin Pathol       Date:  1978-02       Impact factor: 3.411

View more
  39 in total

1.  Contamination of burn wounds by Achromobacter Xylosoxidans followed by severe infection: 10-year analysis of a burn unit population.

Authors:  A Schulz; W Perbix; P C Fuchs; H Seyhan; J L Schiefer
Journal:  Ann Burns Fire Disasters       Date:  2016-09-30

2.  [(3)H]Adenine is a suitable radioligand for the labeling of G protein-coupled adenine receptors but shows high affinity to bacterial contaminations in buffer solutions.

Authors:  Anke C Schiedel; Heiko Meyer; Bernt B A Alsdorf; Simone Gorzalka; Hannelore Brüssel; Christa E Müller
Journal:  Purinergic Signal       Date:  2007-07-25       Impact factor: 3.765

Review 3.  The role of water in healthcare-associated infections.

Authors:  Brooke K Decker; Tara N Palmore
Journal:  Curr Opin Infect Dis       Date:  2013-08       Impact factor: 4.915

4.  Achromobacter xylosoxidans Cellular Pathology Is Correlated with Activation of a Type III Secretion System.

Authors:  Adam M Pickrum; Orlando DeLeon; Aaron Dirck; Maxx H Tessmer; Molly O Riegert; Julie A Biller; Nathan A Ledeboer; John R Kirby; Dara W Frank
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

5.  Nosocomial outbreak of Achromobacter xylosoxidans associated with a diagnostic contrast solution.

Authors:  J Reina; M Antich; B Siquier; P Alomar
Journal:  J Clin Pathol       Date:  1988-08       Impact factor: 3.411

6.  In vitro susceptibility of Alcaligenes denitrificans subsp. xylosoxidans to 24 antimicrobial agents.

Authors:  Y Glupczynski; W Hansen; J Freney; E Yourassowsky
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

7.  Achromobacter xylosoxidans bacteremia.

Authors:  J P Manzella
Journal:  Dig Dis Sci       Date:  1987-07       Impact factor: 3.199

8.  Bacteremia and urinary tract infection associated with CDC group Vd biovar 2.

Authors:  K G Van Horn; C A Gedris; T Ahmed; G P Wormser
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

9.  Neonatal meningitis caused by Achromobacter xylosoxidans.

Authors:  S S Namnyak; B Holmes; S E Fathalla
Journal:  J Clin Microbiol       Date:  1985-09       Impact factor: 5.948

10.  Pulmonary Infection Caused by Achromobacter xylosoxidans in a Patient with Carcinoma of Epiglottis: A Rare Case.

Authors:  Priyamvada Roy
Journal:  J Clin Diagn Res       Date:  2014-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.